Literature DB >> 6782239

Aminophylline may stimulate respiration in rats by activation of dopaminergic receptors.

D B Lundberg, G R Breese, R A Mueller.   

Abstract

In intact young rats anesthetized with halothane, aminophylline produces an increase in respiratory minute ventilation due primarily to an increase in respiratory frequency. Although the simulation of respiration by inhalation of 10% CO2 is augmented only at high doses of aminophylline, the response to CO2 is increased at doses as low as 3 mg/kg of aminophylline. Division of the ninth cranial nerve together with removal of the carotid body did not alter the response, whereas vagotomy changed the response from one of increased frequency to an increase in tidal volume. Both awake and anesthetized rats evidence a decrease in PaCO2; after aminophylline administration and in awake animals, a decrease in brain stem dopamine content was observed. Since haloperidol, a dopamine antagonist, blocked the response to aminophylline, it seems likely that aminophylline may stimulate respiration by altering dopamine receptor activation in the brain.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782239

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Is GABA involved in the development of caffeine tolerance?

Authors:  S Mukhopadhyay; M K Poddar
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

2.  Lung function, hypoxic and hypercapnic ventilatory responses, and respiratory muscle strength in normal subjects taking oral theophylline.

Authors:  S Javaheri; L Guerra
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Behavioral and pharmacological modulation of respiration in rhesus monkeys.

Authors:  L L Howell; A M Landrum
Journal:  J Exp Anal Behav       Date:  1994-07       Impact factor: 2.468

4.  Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses.

Authors:  M Herrera-Marschitz; M Casas; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.